0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Three Daughters, Three Journeys - Quest for Cancer Cure (Hardcover) Loot Price: R1,039
Discovery Miles 10 390
Three Daughters, Three Journeys - Quest for Cancer Cure (Hardcover): Jill Charles, Indrani Mondal, Ranjita Chattopadhyay,...

Three Daughters, Three Journeys - Quest for Cancer Cure (Hardcover)

Jill Charles, Indrani Mondal, Ranjita Chattopadhyay, Ananda Chakrabarty

 (sign in to rate)
Loot Price R1,039 Discovery Miles 10 390 | Repayment Terms: R97 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Cancer threatens the lives of people around the world. Women, in particular, are at risk of certain cancers with a genetic cause. Certain mutations in the BRCA1 and BRCA2 genes put mothers and daughters at risk of breast and ovarian cancers. Unlike many cancers that most commonly occur after age 60, these inheritable cancers threaten women's lives, health and fertility even when they are young, before most would even begin to go for annual mammogram screenings to check for breast cancer. Three Daughters, Three Journeys takes on the biggest health issue of our time from a global perspective with three heroines fighting for their lives against cancer. Marzena, a Polish oncology nurse, has spent her life treating child patients with cancer. Then, she confronts it in her own family and her own body. Kamola, a rural Indian girl, knows she has symptoms of the same disease that took her mother, but feels afraid to discuss it with her father and brothers, knowing her family cannot afford medical treatment. Kamola confides in Dr Rini Mishra, a doctor testing a new treatment called Neelazin, using a bacterial anticancer protein in food, to destroy cancer cells. Selena, a wealthy woman of color in Chicago, finds out about her genetic risks of breast and ovarian cancer. She has a choice of preventative surgery that will save her life but remove any chance of having children. As she meets women who struggle to afford cancer treatment, Selena dedicates her life to providing affordable homes and counseling to families affected by the disease. Although the drug Neelazin is fictional, the possibility of new cancer treatments using bacterial anticancer proteins is being researched now. A problem with the current chemotherapy for cancer treatment is the high toxicity of most of these drugs, as these drugs can enter both normal and cancer cells, though preferably cancer cells, causing the death of normal cells as well that are important in maintaining health. Another problem is that current chemotherapeutic drugs mostly target a single or few key steps that are important for cancer growth and proliferation and inhibit the growth of cancer cells. The cancer cells respond by quickly changing these single targets, thereby becoming resistant to the drugs, as is reflected in stage IV cancer patients. An alternative to chemotherapy would be to exploit the bacterial evolutionary wisdom and use certain proteins that can have preferential entry to cancer cells in order to minimize normal cell toxicity and multiple targets in cancer cells through protein-protein complex formation, thus reducing resistance development in cancer cells. An interesting advantage of protein drugs is to express them as part of food, and some recent research seems to suggest that oral consumption of such foods may allow the therapeutic protein to reach the blood stream to target the cancer. Women with the genetic risk factors could soon have the choice of taking a pill or such anticancer protein-expressing food to treat or prevent cancer, rather than removing the healthy tissue of the breasts and ovaries. Hopefully, they would not have to choose between fertility and survival, as is the implied message in this book, fictional as it is at this time.

General

Imprint: Pan Stanford Publishing Pte Ltd
Country of origin: Singapore
Release date: May 2017
First published: 2017
Authors: Jill Charles • Indrani Mondal • Ranjita Chattopadhyay • Ananda Chakrabarty
Dimensions: 229 x 152 x 19mm (L x W x T)
Format: Hardcover
Pages: 166
ISBN-13: 978-981-4745-90-1
Categories: Books > Medicine > General issues > Public health & preventive medicine > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Genetics (non-medical) > General
Promotions
LSN: 981-4745-90-1
Barcode: 9789814745901

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Targeted Nanomedicine for Breast Cancer…
Shivani Rai Paliwal, Rishi Paliwal Paperback R4,659 Discovery Miles 46 590
Encyclopedia of Infection and Immunity
Nima Rezaei Hardcover R60,916 Discovery Miles 609 160
Immunotherapy in Resistant Cancer: From…
Jorge Morales Montor, Mariana Segovia Hardcover R3,632 Discovery Miles 36 320
Sphingolipids in Cancer, Volume 140
Charles E. Chalfant, Paul B. Fisher Hardcover R3,879 Discovery Miles 38 790
Lung Cancer, An Issue of…
Roy S. Herbst, Daniel Morgensztern Hardcover R2,192 Discovery Miles 21 920
Adjunctive Rehabilitation Approaches to…
Andrea L. Cheville Hardcover R2,194 Discovery Miles 21 940
Pediatric Brain Tumors Update, An Issue…
Lara Brandao Hardcover R2,210 Discovery Miles 22 100
Neuroendocrine Tumors, An Issue of…
Jennifer Chan, Matthew Kulke Hardcover R1,744 Discovery Miles 17 440
Geriatric Oncology, An Issue of Clinics…
Harvey J. Cohen, Arati V Rao Hardcover R1,742 Discovery Miles 17 420
Pulmonary Metastasectomy, An Issue of…
Mark W Onaitis, Thomas A. D'Amico Hardcover R2,587 Discovery Miles 25 870
Testicular Cancer, An Issue of Urologic…
Daniel W. Lin Hardcover R1,746 Discovery Miles 17 460
Bladder Cancer, An Issue of…
Joaquim Bellmunt Hardcover R1,740 Discovery Miles 17 400

See more

Partners